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Abstract 
Advanced technology in molecular biology often uses microorganism, consequently, researcher 
should have a responsibility in producing of laboratory products safely both for human and 
their environment. This presentation was intended (1) to report recombinant protein research in 
the Jembrana Disease Virus (JDV); (2) to identify relevancy of the ethics towards the research 
of recombinant protein and (3) to discuss relationship of utilitarianism principle with the 
development of the recombinant protein. The Jembrana disease is an infectious virus caused by 
a virus classified as retrovirus of Retrovidae family. The disease only attacks Bali cattle (Bos 
javanicus) that caused about 20% mortality rate. Up to present, crude vaccine from lymph 
organ of acute infected Bali cattle is often used for vaccination. Development of the Jembrana 
vaccine was attempted to increase the availability of qualified Jembrana vaccine by 
recombinant DNA approaches subsequently could be used as vaccine substances. This article 
was presented with much bioethics issues in associated with recombinant protein research and 
other examples of related research which use micro-organism in their investigation. It is 
expected that bioethics could be a restrain for researchers who deal with advanced technology in 
their investigation.      
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Abstrak 
Teknologi maju pada biologi molekuler sering menggunakan mikroorganisme, maka peneliti 
dituntut untuk menghasilkan produk laboratorium yang aman baik untuk manusia maupun 
lingkungannya. Penelaahan ini dimaksudkan untuk (1) melaporkan penelitian protein 
rekombinan pada virus penyakit Jembrana; (2) mengidentifikasi relevansi dari segi etik 
terhadap penelitian protein rekombinan dan (3) membahas hubungan prinsip utilitarianisme 
dengan pengembangan vaksin rekombinan. Penyakit Jembrana adalah penyakit infeksi dan 
mematikan, disebabkan oleh virus kelompok retrovirus dari keluarga Retrovidae. Penyakit ini 
menyerang khusus sapi bali (Bos javanicus) dan menyebabkan rata-rata kematian fatal 20%. 
Sampai sekarang, crude vaccine dari organ lymfa sapi bali terinfeksi akut penyakit jembrana 
digunakan untuk vaksinasi. Pengembangan vaksin Jembrana diusahakan untuk meningkatkan 
ketersediaan vaksin Jembarana berkualitas dengan pendekatan teknologi DNA rekombinan 
selanjutnya dapat digunakan sebagai bahan vaksin. Artikel ini disajikan dengan banyak isu 
bioetika dalam hubungannya penelitian protein rekombinan dan contoh penelitian lain 
berkaitan menggunakan mikroorganisme. Diharapkan bioetika dapat menjadikan pengerem 
peneliti yang menggunakan micro-organism dalam menjalankan penelitiannya.  
Kata kunci: Prinsip utilitarianisme, vaksin recombinan, penyakit jembrana, sapi Bali 
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Introduction 
In 17
th
 century, Aristotle had focused on 
scientific concerns, and the science has 
progressed rapidly and more widely in molecular 
biology. Nowadays there are several societies 
emerging concomitantly with the rapid progress 
of advanced technology in some specific science 
interests. In the beginning of 21
st
 century, the 
progress of science and sustainable development 
of societies are very dependent of each other 
(Airaksinen, 1995). It was discussed in the 
Societas Ethica meeting of science and 
development progress of societies have warned 
us that ethics and science have become 
important elements for both interests of science 
and those of society. It is as reminded by Behm 
(2005) that research ethics is recognized widely 
as an important feature of scientific practice. 
There are three human interests towards 
knowledge, those are technical, practical and 
emancipatory (Habermas, 1971). Technical 
interests can be found behind natural sciences 
and behind some systematic social sciences, 
practical interest lies behind humanistic sciences 
while emancipatory interest lies behind critical 
social sciences. Based on the Haberman’s 
interests, it is clear that researchers need to 
perform their research works wisely and 
responsibly for living organism and 
environment.     
When researchers deal with research using 
living organism or something alive then they 
need to be concern with bioethics. There are 
many definitions of bioethics, most of them 
control the effect of research works to human 
and environment. However, when we line up 
with focus on research purposes then we get the 
same red line that we need to be aware to the 
environment in wider meaning.     
Have you been thinking that someday life 
in the world could be extinct due to no 
medicines for recovering or healing illness? In 
one side, the existence of advanced technology is 
based on molecular level offering ease, 
efficiency and little expense in terms of mass 
production. In other side, there is still a gap of 
fear resulting from breakthrough of the advanced 
technology. Mankind have been granted mind 
and soul, in the other hand, they also need to 
improve a high qualified, cheaper, safer and 
useful medical material for a wider mankind.  
Starting from the above statement, 
bioethics comes in the middle of a higher life 
demand that has to be fulfilled for sustainability 
of their life. Therefore, the definition of 
bioethics needs to be understood carefully and 
wisely. Bioethics is a combine of several 
disciplines of knowledge concerning on ethics, 
legality and social questions (worries) that 
emerged as the effect of development in 
medicines, science and biotechnology (Mepham, 
2005). Advances in science with molecular-
based technology as a tool, this will be useful to 
cope with the lack of food and medicine 
availability, as long as the advanced technology 
and material research are chosen wisely. This 
option of doing research meets to the definition 
of bioethics which is stated as the study of moral 
and social implications of techniques resulting 
from advances in the biological sciences 
(Mepham, 2005).  
As stated by first bioethicist of Aldo 
Leopold that “A thing is right when it tends to 
preserve the integrity, stability, and beauty of the 
biotic community. It is wrong when it tends 
otherwise" (Leopold, 1949). This statement 
reminds us that human being should be 
responsible in using the natural sources wisely. 
Another definition stated that bioethics is actually 
not a discipline, but it has become a meeting 
ground for a number of disciplines, discourses, 
and organizations concerned with ethical, legal, 
and social questions raised by advances in 
medicines, science, and biotechnology (O’Neill, 
2002; Mepham, 2005). Those definitions are 
clear that both concerned with implication of 
using of advanced technology for producing 
huge number of medical products.    
Creating biological medicines is also 
needed for animal welfare as another organism 
on earth, which will be discussed in this article 
as a case study in producing vaccine. Entering 
biotechnology era, it is very possible to develop 
the Jembrana vaccine by applying a recombinant 
DNA technology to produce recombinant viral 
protein as a recombinant vaccine for controlling 
the Jembrana disease in Bali cattle. 
As local beef cattle in Indonesia, Bali 
cattle are recognized as one of gene pools beef 
cattle in South-East Asia, it has superiority in 
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reproduction of one year in calving interval. In 
spite of that reproductive superiority, Bali cattle 
have other superiority in meat characteristics, 
i.e., lean, juicy and smooth texture of muscular 
fiber. However, Bali cattle have inferiority in 
susceptibility of Jembrana disease virus (JDV), 
Chadwick et al., (1995). The fatal mortality rate 
of Jembrana disease was recorded about 20% in 
1964 (Moll, 1998). In the past colonization by 
Dutch, Bali cattle were restricted rearing in Bali 
Island to prevent their genetic purity. By the 
time and up to present, distribution of Bali cattle 
is wider throughout Indonesia. The disease is 
then transmitted to other islands and the need of 
Jembrana vaccine is therefore increased. 
Recently, vaccination is performed by using 
crude tissue-derived vaccine (Hartaningsih and 
Wilcox, 1996; Hartaningsih et al., 2001). 
Processing of the crude vaccine is costly, due to 
using infected lymph or spleen organs of fresh 
slaughtered Bali cattle. The disadvantage of the 
crude vaccine is a low quality, expensive, low 
production, and difficult to handle in the field.  
Advancing in recombinant DNA and more 
popular technology for medicine research is 
recombinant protein. Jembrana disease virus 
(JDV) belongs to lentivirus group of 
Retroviridae family (Wilcox et al., 1995). The 
JDV genome (7732bp) consists of at least three 
major genes (gag, pol and env) encoding 
proteins that needed for virus replications 
(Chacdwick et al., 1995). Moreover, it was 
stated that the env gene encodes TM and SU 
proteins on the surface of the virus and most 
attempts to induce a protective immunity against 
lentivirus infection. Another immunogenic viral 
protein is Tat that is coded by tat gene. The tat 
gene is one of small accessory genes and lies 
between gag and pol genes. In recent study, 
those three Jembarana genes were cloned into a 
plasmid vector in a pGEX system. The obtained 
clones were transformed through a host cell of 
Escherichia coli (E. coli) to express their 
recombinant proteins. The host cell of E. coli is 
very common in expression of recombinant 
protein since they can multiply quicker in cell 
numbers bearing the recombinant proteins. 
Therefore, most recombinant protein is always 
purified from E. coli after cloning on the gene 
into expression vectors (Studier and Moffatt, 
1986). 
A Case Study on Recombinant Protein 
Research in Jembrana Disease Virus (JDV) 
At least three proteins of SU (superficial 
unit), TM (transmembrane) and Tat were 
considered as potential candidates for a 
protective vaccine against Jembrana disease for 
Bali cattle (ACIAR report, 2004). The TM and 
SU proteins were encoded by env gene while Tat 
protein was encoded by tat gene. By polymerase 
chain reaction (PCR), those three gene fragments 
were amplified then constructed in pGEX 
system. Therefore, to express proteins the 
constructs need to be transformed into a host cell 
of BL21 strain of Escherichia coli as a 
manufacturer of producing the proteins. 
Production of the recombinant proteins for JDV 
is possible as the genes encoding the proteins 
have been well-characterized (Chadwick et al., 
1995).  
When cloning of JSU, JTM and JTat were 
performed using pGEX system in which the 
proteins were fused with GST tag, the expression 
and purification of those clones were also 
conducted in pGEX system. The molecular size 
of GST tag is ± 26kDa (Amershampharmacia 
biotech, 1997), while molecular weights of JSU, 
JTM and JTat are ±34, ±10 and ±10.7kDa, 
respectively. Therefore, when proteins were 
fused to the GST tag, they resulte recombinant  
proteins with size of ± 60, ± 36 and ± 36.7kDa 
for JSU, JTM and JTat, respectively. The 
purification and characterization of those proteins  
were conducted by SDS-PAGE and Western 
blotting (WB) methods. Constructing of JTat 
was also conducted in pET system where the 
system used a 6-histidine tag which has a 
molecular size of less than 1 kDa. Creating JTat 
construct in pET system was aimed to increase 
the efficacy of the resulted recombinant protein 
of JTat. Expression of JTat was transformed in 
BL21 E. coli. The protein fused with his-tag can be 
purified by chromatography affinity on 
Immobilized Metal-ion Affinity Chromatography 
(IMAC), (Bosch et al, 2001).  
Those recombinant proteins are the virus 
attachment protein which initiates the first 
interaction of the virus and the infected cells. 
Antibody capable of binding with the protein 
will be likely preventing the viral infection 
(Barnett et al., 2001). In the case of JTat 
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recombinant protein is a minor protein required 
by the virus to activate the transcription of the 
viral genome into mRNA which is necessary for 
the efficient replication of the virus in the 
infected host (Cota-Gomez et al., 2002; Wu, 
2004). Immune response against the protein is 
expected to be able to slow down or completely 
stop the viral replication. 
Laboratory scale production was initiated 
to get a small volume of recombinant proteins 
which used to field trial in Bali cattle in the 
disease investigation centre in Denpasar, Bali. 
Those three recombinant proteins were used in 
the field trial, and the result showed good 
response in resulting antibody. Scaling up of the 
recombinant proteins is needed to be conducted 
in a manufacturer of biomedical industry. 
The Relevant of Ethical Features to the JDV 
Recombinant Protein Research 
In fact, there are only few articles 
published on the ethical reflections on molecular 
technology. In biomedical production, it is rather 
impossible to be produced conventionally in this 
recent era. For human needs, increasing 
population in the world would tend to increase 
the problems in health due to the rapid 
development of industries for many purposes. 
The effect of industrial process, increasing 
transportation and changing the green view of 
trees into buildings creates pollutant. This 
implies that the people’s health decrease and the 
needs of medicines increase drastically. The 
availability of medicines would need to be 
accelerated to balance with the increase of 
human population. The discovery in molecular 
biology technology contributes significantly in 
increasing wider products such as in agriculture, 
medicine, energy, etc. In agriculture base, 
introduction of advanced technology in food 
production (cereal, paddy, corn, etc.) is the most 
important and significant in the world. The 
increasing of animal population is also important 
as protein source from livestock. This protein 
source derived from livestock consists of more 
complete in number of amino acids compared to 
that protein source from plant. Similar to human, 
population of livestock can tend to decrease due 
to infection by some diseases or less feed.  
Jembrana disease is an acute, a severe 
disease and endemic in Bali cattle (Bos 
javanicus). The disease caused a 20% case 
mortality rate after a short incubation period in 
Bali cattle (Moll, 1998). However, in the later 
publication, the JDV has infected also to other 
cattle types and buffalo during experiment and 
field condition (Soeharsono et al., 1995). 
Nowadays, preventing to Jembrana disease in 
Bali cattle has been using crude vaccine for its 
vaccination (Hartaningsih and Wilcox, 1996; 
Hartaningsih et al., 2001). The crude vaccine is 
provided from infected tissue of Bali cattle by 
Jembrana viruses. Availability of this crude 
vaccine is limited compared to recent population 
of Bali cattle in the field. Despite limited in 
production, the crude vaccine is also costly, less 
effective and demanding in vaccine 
maintenance.  
Entering biotechnology era, it is possible 
to develop a conventional vaccine such as 
Jembrana vaccine by recombinant DNA 
technology to produce recombinant viral protein 
as Jembrana vaccine. Development of 
recombinant protein for potential vaccine was 
initiated by colleagues at Murdoch University 
for Jembrana disease virus (JDV). The initiation 
of producing a recombinant Jembrana vaccine is 
expected to solve some problems associated with 
disadvantages of the current crude vaccine. This 
recombinant Jembrana vaccine is a safer, 
effective and lower cost in production process.  
The consideration of using advanced 
technology was intended to develop the existing 
Jembrana crude vaccine that was produced 
conventionally. The researchers should decide 
independently in choosing the manner of doing 
their research as long as it is still safe and 
follows principles of biomedical ethics. The 
principles of biomedical ethics as stated by 
Beauchamp and Childress (2001) consist of 
respect to autonomy (independency in decision-
making); justice (fair treatment and equity); 
beneficence (doing the good thing); and non-
maleficent (to do no harm). 
Researchers should concern to the 
tendency of people population in the world. 
Based on Malthus Theory (1798), it was featured 
that world population increasing exponentially: 
2, 4, 8, 16 etc. while food production increasing 
linearly: 1, 2, 3, 4 etc., then human population in 
2002 was 6,137 million (4,944 million were in 
developing countries) with increasing rate of 
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1.3% per annum. Therefore, it is no point that we 
have to do something to meet with those world 
features in order to get a secure living in 
harmony with nature. The decision of doing 
something is not easy to implement it to the 
research as reminded by Abu Ali al-Husain ibn 
Abdallah ibn Sina (Avicenna), 980-1037 
(http://www-history. mcs.st-
andrews.ac.uk/Mathematicians/Avicenna. html, 
1999). His statement was “In science, 
humankind is (still) looking for a harmonious 
relationship with nature, and seeking to know it 
and conform to it”. 
In science, there are many things to be 
taken and decided with as much as zero risk to 
meet with goals to create living in harmony. To 
implement this statement, a researcher will use 
advanced technology as a tool based on 
molecular biology; some will work on 
genetically engineered organism or genetically 
modified organism. Those laboratory works will 
increase the productivity of food or medicines. 
However, researchers should always control of 
their work in using the tool and research 
material. It is reminded by first bioethicist Aldo 
Leopold (1949) that “A thing is right when it 
tends to preserve the integrity, stability, and 
beauty of the biotic community. It is wrong 
when it tends otherwise”.      
The Integration of Utilitarianism Principle to 
the Producing of JDV Recombinant Vaccine 
Along with the use of tools wisely, 
development of Jembrana vaccine was aimed to 
fulfill the vaccine needs in a large number due to 
the increase of Bali cattle population. To achieve 
this goal, researchers do not have to choose the 
right and a wise tool. A recombinant DNA  
technology and more precisely recombinant 
protein technology is an approach to answer the 
needs of Jembrana vaccine lately.  
The aim of using the advanced technology 
is to construct a specific gene target into a 
plasmid vector, then it is transformed into an E. 
coli host cell. In the culture, the host cell of E. 
coli will be multiplied in numbers then 
recombinant proteins are expressed in side of the 
cells. Methods of SDS-PAGE and Western 
Blotting are used for characterization and 
purification of the recombinant proteins. The 
yield of recombinant proteins through 
implementation of recombinant DNA technology 
is extremely in huge number. The product of 
recombinant proteins is potential as a Jembrana 
recombinant vaccine. As stated in the previous 
chapter, those potential recombinant proteins are 
JSU, JTm and JTat. Those kinds of recombinant 
proteins are much more qualified vaccine 
because they are obtained from targeted gene of 
Jembrana viral genome compared to that of 
crude vaccine. The crude vaccine is not only 
expensive in processing since the process has to 
kill the Bali cattle, which is infected, to get 
lymph organ but the crude vaccine is also not 
targeting. It is because we do not know exactly 
that the killed cattle were infected by the single 
disease of the Jembrana virus.  
Compared to the conventional process to 
obtain the crude vaccine, the recombinant  vaccine 
has some advantages. The recombinant vaccine 
can be produced cheaper in mass production, 
more qualified (because of more targets) and 
more practical in handling them in the field. This 
mass production comes along with the increase 
of Bali cattle population recently which is not 
only in Bali Island but spread wider throughout 
Indonesian islands.   
In line with the processing of recombinant 
protein production, recombinant vaccine could 
be produced in a large yield through E. coli. This 
research act is an implementation of biomedical 
ethics principles: respect to autonomy, justice, 
beneficence and non-maleficent (Beauchamp 
and Childress, 2001). In doing biomedical 
research, researchers have responsibility for the 
products therefore they should be careful and 
always concern with biomedical ethics.  
Many medicine products have been 
processed through GMO (genetically modified 
organism) or GEO (genetically engineered 
organism) to get mass production so that people 
in the world would be safer from illness. 
Researchers conducting those processes both in 
the laboratory and in the field trial have to take 
the safety into account. At least, one of two 
principles in ethical theory becomes the 
foundation resulting from the research processes, 
this is Utilitarianism principle while another is 
Deontology principle (responsible and entitle of 
each individual to another individual), (Bentham, 
1907; Mill, 1998). There is an integration of 
producing recombinant protein in a large number 
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to the Utilitarianism principle. The Utilitarianism 
principle follows the concept of producing the 
greatest good for greatest numbers. The greatest 
good in such matter is recombinant protein 
product which is the qualified product with 
targeted immunity while the greatest numbers 
are meant as a large yield producing from 
manufacturing through E. coli as a host cell. 
Researchers’ respect in the laboratory and in the 
field is expected to create harmony among 
human being and other individuals.  
Conclusion and Suggestion 
Most of research in biotechnology that 
applies advanced technologies often uses living 
organism. In vaccine development for Jembrana 
disease in Bali cattle, a series of research 
activities was conducted such as constructing a 
clone then transformed into a host cell of 
microorganism in order to express recombinant 
protein in huge numbers. This activity agreed 
with one principle in bioethics which is 
utilitarianism principles “Producing the greatest 
good for greatest”. In this case, researchers 
should be aware that everything produced from 
their research should be safe for users or animals 
in this case. Bioethics is therefore should be 
always reminding researchers to be wise in 
conducting and resulting creativity in their 
research.   
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